| Stakk Limited (SKK) ORDINARY FULLY PAID |
Information Technology |
$59 |
Stakk Reports $5.52m Quarterly Revenue
|
28 Apr 2026 8:55AM |
$0.020 |
$0.019 |
fallen by
5%
|
|
SKK - Price-sensitive ASX Announcement
Full Release
Key Points
- Stakk reports a quarterly revenue of $5.52 million, a 186% increase from the previous quarter.
- The company's revenue is predominantly recurring, with a zero-churn client book over the past 24 months.
- Gross margin exceeds 85%, highlighting the scalability and quality of earnings.
- Approximately A$2.7 million in annualised recurring revenue is expected to convert to active billing in the next 120 days.
- Cash receipts for the quarter were $5.36 million, closely aligned with booked revenue.
- Net cash increased by $2.25 million, improving from the previous quarter's outflow.
- Stakk's AI-native execution-layer capabilities are driving client acquisition and revenue growth.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| St George Mining Limited (SGQ) ORDINARY FULLY PAID |
Materials |
$474 |
Quarterly Activities and Cashflow Report
|
28 Apr 2026 8:54AM |
$0.130 |
$0.120 |
fallen by
7.69%
|
|
SGQ - Price-sensitive ASX Announcement
Full Release
Key Points
- 75% increase in Mineral Resource Estimate at Araxá Project to 70.91Mt
- Araxá Project ranks as a major global deposit for rare earths
- Land acquired for potential processing facilities
- Alliances formed with companies like REalloys, Boston Metal, and Tecnicas Reunidas
- Current cash balance is approximately $43 million
- St George included in the S&P/ASX All Ordinaries Index
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| LGI Limited (LGI) ORDINARY FULLY PAID |
Utilities |
$357 |
Appointment of CFO & Change to CEO's Remuneration
|
28 Apr 2026 8:54AM |
$3.600 |
$3.450 |
fallen by
4.17%
|
|
| Ballymore Resources Limited (BMR) ORDINARY FULLY PAID |
Materials |
$27 |
Broad, shallow gold intersections near Mt Leyshon gold mine
|
28 Apr 2026 8:54AM |
$0.135 |
$0.130 |
fallen by
3.70%
|
|
BMR - Price-sensitive ASX Announcement
Full Release
Key Points
- Broad, shallow gold intersections identified at Seventy Mile Mount.
- Significant drill results include 84.5m at 0.247 g/t Au and 56m at 0.456 g/t Au.
- Potential for a large, bulk-tonnage gold operation.
- Project located in the Mount Leyshon Corridor, a prolific gold region.
- Further drilling planned to expand mineralized zones and assess resource potential.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| LTR Pharma Ltd (LTP) ORDINARY FULLY PAID |
Health Care |
$68 |
Quarterly Activities/Appendix 4C Cash Flow Report
|
28 Apr 2026 8:52AM |
$0.430 |
$0.375 |
fallen by
12.79%
|
|
LTP - Price-sensitive ASX Announcement
Full Release
Key Points
- Completion of SPONTAN Phase II pharmacokinetic study recruitment.
- Interim pharmacokinetic data expected in Q2 CY2026.
- Progress in ROXUS US commercial strategy via FDA 503(a) pathway.
- Strong cash position with A$24.1 million balance and no debt.
- Net cash outflow of A$1.8 million for the quarter.
- Focus on expanding real-world evidence through TGA Special Access Scheme.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Resolution Minerals Ltd (RML) ORDINARY FULLY PAID |
Materials |
$114 |
Tungsten Concentrates Produced from Golden Gate
|
28 Apr 2026 8:51AM |
$0.070 |
$0.051 |
fallen by
27.14%
|
|
RML - Price-sensitive ASX Announcement
Full Release
Key Points
- Resolution Minerals Ltd (ASX: RML) produced tungsten concentrates of 52.3% tungsten trioxide (WO3) from stockpiles at Golden Gate.
- The Heavy Liquid Separation (HLS) scoping tests achieved an upgrade ratio of 19, indicating tungsten is amenable to gravity flotation processes.
- Test work is progressing, with further testing on a larger 50kg sample and concentration via shaker table.
- Historical mining at Golden Gate occurred between the 1950s and 1980s, and the area is part of Resolution's Horse Heaven project in Idaho, USA.
- The tungsten stockpiles are sourced from historical mining at Golden Gate Tungsten mine, with scheelite identified as the primary WO3 mineral.
- Resolution is planning a major drilling program at Golden Gate to define gold and tungsten mineralization.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Hammer Metals Limited (HMX) ORDINARY FULLY PAID |
Materials |
$38 |
Copper, Gold, Molybdenum Drilling Commences at Kalman
|
28 Apr 2026 8:51AM |
$0.033 |
$0.043 |
risen by
30.30%
|
|
HMX - Price-sensitive ASX Announcement
Full Release
Key Points
- Reverse Circulation (RC) drilling program commenced at Hammer’s Mount Isa copper-gold project.
- Targets include Kalman, Lady Jenny, and Blackrock.
- Drilling aims to upgrade Resources and test shallow mineralization.
- Drilling expected to complete in May with results late May.
- Resource update at Kalman to inform a Scoping Study.
- Kalman deposit has potential for copper, gold, molybdenum, and rhenium.
- Recovery assumptions for copper, gold, silver, molybdenum, and rhenium detailed.
- Prices for commodities used in copper equivalent calculations listed.
- Hammer Metals holds strategic tenement in Mount Isa mining district.
- Hammer Metals is focused on discovering large copper-gold deposits.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Clinuvel Pharmaceuticals Limited (CUV) ORDINARY FULLY PAID |
Health Care |
$460 |
CLINUVEL update on Level II ADR upgrade, Nasdaq uplist
|
28 Apr 2026 8:50AM |
$8.980 |
$9.130 |
risen by
1.67%
|
|
CUV - Price-sensitive ASX Announcement
Full Release
Key Points
- Clinuvel engaging with SEC for ADR upgrade
- Expected completion of SEC review by June 2026
- Plan to list on Nasdaq as CUVL post-SEC review
- No final decision on uplisting; subject to SEC and Nasdaq requirements
- Clinuvel's focus on innovative treatments and global expansion
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Catalina Resources Ltd (CTN) ORDINARY FULLY PAID |
Materials |
$8 |
Exploration Expanded at Beasley Creek & EIS Funding Secured
|
28 Apr 2026 8:49AM |
$0.063 |
$0.050 |
fallen by
20.63%
|
|
CTN - Price-sensitive ASX Announcement
Full Release
Key Points
- Exploration at Beasley Creek expanded with the Flamingo Target confirmed as part of a broader Cu–Au hydrothermal corridor.
- Two additional priority targets, Golden Hand and King Brown, identified along the Mithgoondy Shear Zone.
- Initial drill collars defined at Flamingo, progressing towards first-pass drilling by July-August 2026.
- Up to $180,000 in co-funding awarded under the WA Government’s EIS for drilling at Flamingo.
- Ongoing soil sampling and geological assessments to refine and prioritize targets for drilling.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| KKR Credit Income Fund (KKC) ORDINARY UNITS FULLY PAID |
Financials |
$664 |
Net Tangible Asset Backing
|
28 Apr 2026 8:47AM |
$2.080 |
$2.060 |
fallen by
0.96%
|
|
| Resonance Health Limited (RHT) ORDINARY FULLY PAID |
Health Care |
$20 |
Director Appointments
|
28 Apr 2026 8:47AM |
$0.044 |
$0.041 |
fallen by
6.82%
|
|
| European Resources Limited (ERE) ORDINARY FULLY PAID |
Materials |
$8 |
Quarterly Activities/Appendix 5B Cash Flow Report
|
28 Apr 2026 8:45AM |
$0.014 |
$0.011 |
fallen by
21.43%
|
|
ERE - Price-sensitive ASX Announcement
Full Release
Key Points
- Korsnäs project drilling program completed with strong results.
- Inferred Mineral Resource Estimate increased to 15.4Mt @ 1.00% TREO.
- High-grade NdPr enrichment observed in drilling results.
- Metallurgical advancements with GTK, ANSTO, and others.
- Renounceable rights issue planned to raise up to $3.4 million.
- Cash and cash equivalents decreased; expenditures focused on exploration.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| True North Copper Limited (TNC) ORDINARY FULLY PAID |
Materials |
$75 |
Mt Oxide drilling commences to expand Aquila Discovery
|
28 Apr 2026 8:44AM |
$0.455 |
$0.495 |
risen by
8.79%
|
|
| McPherson's Limited (MCP) ORDINARY FULLY PAID |
Consumer Staple |
$19 |
Update - Notification of buy-back - MCP
|
28 Apr 2026 8:44AM |
$0.150 |
$0.130 |
fallen by
13.33%
|
|
| INOVIQ Ltd (IIQ) ORDINARY FULLY PAID |
Health Care |
$46 |
Quarterly Activities Report and Appendix 4C - March 2026
|
28 Apr 2026 8:43AM |
$0.320 |
$0.325 |
risen by
1.56%
|
|
IIQ - Price-sensitive ASX Announcement
Full Release
Key Points
- INOVIQ Limited focuses on exosome-based diagnostics and therapeutics for cancer detection and treatment.
- The quarterly report outlines activities and financial results up to March 31, 2026.
- INOVIQ's flagship EXO-OC™ test for ovarian cancer is progressing with clinical studies expected to complete by June 2026.
- The company is advancing its CAR-exosome therapeutics program, with new data expected to be reported in 2026.
- INOVIQ had a cash balance of $11.9 million at the end of March 2026.
- Cash used in operating activities for the quarter was $1.777 million.
- INOVIQ is prioritizing partnerships and commercialization efforts to drive future growth.
- The report includes financial details and progress on various research and development projects.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Adheris Health Limited (AHE) ORDINARY FULLY PAID |
Health Care |
$13 |
3Q FY26 Quarterly Activity Report and Appendix 4C
|
28 Apr 2026 8:42AM |
$0.022 |
$0.020 |
fallen by
9.09%
|
|
AHE - Price-sensitive ASX Announcement
Full Release
Key Points
- Q3 FY26 operating revenue of $5.4m, down 23.9% from Q3 FY25.
- Gross profit decreased by 36.7% to $2.1m.
- Received a $6.1m holdback payment from the sale of the ANZ business.
- Net cash at the period end of $9.4 million.
- Targeting cash flow break-even in Q4 FY26.
- Implemented cost reduction and revenue diversification strategies.
- Enhanced technology platform functionality.
- Focus on scalable operations and revenue diversification.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Streamplay Studio Limited (SP8) ORDINARY FULLY PAID |
Communication Services |
$13 |
Quarterly Activities/Appendix 4C Cash Flow Report
|
28 Apr 2026 8:41AM |
$0.012 |
$0.010 |
fallen by
16.67%
|
|
SP8 - Price-sensitive ASX Announcement
Full Release
Key Points
- Cash receipts totaled approximately A$2.54 million.
- Fourth consecutive quarter of positive operating cash flows.
- Continued investment in intellectual property and platform expansion.
- Noodlecake's publishing operations significantly contributed to revenues.
- A$1.8 million in payments related to Noodlecake acquisition.
- No debt at the end of the quarter with A$6.25 million cash balance.
- Strong pipeline for future publishing releases and platform expansions.
- Company is focused on geographic expansion and new market entries.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| AMP Limited (AMP) ORDINARY FULLY PAID |
Financials |
$4,038 |
Update - Notification of buy-back - AMP
|
28 Apr 2026 8:37AM |
$1.440 |
$1.595 |
risen by
10.76%
|
|
| First Graphene Limited (FGR) ORDINARY FULLY PAID |
Materials |
$49 |
Proposed issue of securities - FGR
|
28 Apr 2026 8:37AM |
$0.068 |
$0.056 |
fallen by
17.65%
|
|
| Ariadne Australia Limited (ARA) ORDINARY FULLY PAID |
Industrials |
$93 |
Update - Notification of buy-back - ARA
|
28 Apr 2026 8:37AM |
$0.480 |
$0.480 |
fallen by
0%
|
|
| Echo IQ Limited (EIQ) ORDINARY FULLY PAID |
Information Technology |
$892 |
EchoSolv AS deployed into Mount Sinai Health System
|
28 Apr 2026 8:36AM |
$1.145 |
$1.350 |
risen by
17.90%
|
|
EIQ - Price-sensitive ASX Announcement
Full Release
Key Points
- EchoSolv AS deployed in Mount Sinai Health System, New York
- Mount Sinai Health System includes seven hospitals and over 400 outpatient practices
- Ranked highly in cardiology and heart surgery specialties
- Deployment is part of Echo IQ's US commercial growth strategy
- EchoSolv AS facilitates accurate diagnosis of severe aortic stenosis
- EchoSolv AS intended for use by qualified healthcare professionals
- Echo IQ aims to expand EchoSolv AS adoption in the US
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| First Graphene Limited (FGR) ORDINARY FULLY PAID |
Materials |
$49 |
FGR to acquire advanced graphene coatings companies
|
28 Apr 2026 8:36AM |
$0.068 |
$0.056 |
fallen by
17.65%
|
|
FGR - Price-sensitive ASX Announcement
Full Release
Key Points
- First Graphene Limited enters agreement to acquire Ionic Industries and Imagine Intelligent Materials.
- Acquisition includes manufacturing, intellectual property, and development assets.
- Focus on graphene coatings technologies with proven commercial applications.
- Exposure to geotextile and environmental infrastructure markets.
- Acquisition valued at AU$250,000 in cash and shares.
- Strengthens First Graphene's product suite and accelerates commercialization.
- Geotextile applications improve barrier and conductivity properties.
- Acquisition includes established sales and distribution channels.
- Potential market expansion for advanced graphene solutions in environmental remediation, water treatment, energy storage, and more.
- Acquisition expected to settle within 90 days.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| IPH Limited (IPH) ORDINARY FULLY PAID |
Industrials |
$972 |
Update - Notification of buy-back - IPH
|
28 Apr 2026 8:35AM |
$3.590 |
$3.780 |
risen by
5.29%
|
|
| Algorae Pharmaceuticals Limited (1AI) ORDINARY FULLY PAID |
Health Care |
$23 |
Algorae and Zydus Enter Exclusive Commercial Agreement
|
28 Apr 2026 8:35AM |
$0.012 |
$0.012 |
fallen by
4.17%
|
|
1AI - Price-sensitive ASX Announcement
Full Release
Key Points
- Algorae and Zydus enter exclusive commercial agreement
- Covers injectable, oral, and specialty medicines
- Target markets are Australia and New Zealand
- Supports strategy for a compliant pharmaceutical portfolio
- Collaboration leverages Zydus's global manufacturing capabilities
- Focus on regulatory compliance and market access
- Strengthens Algorae’s commercial platform
- Aims to expand access to quality medicines in regulated markets
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Lion Rock Minerals Limited (LRM) ORDINARY FULLY PAID |
Materials |
$93 |
Quarterly Activities/Appendix 5B Cash Flow Report
|
28 Apr 2026 8:35AM |
$0.022 |
$0.026 |
risen by
18.18%
|
|
LRM - Price-sensitive ASX Announcement
Full Release
Key Points
- High-grade rutile results up to 2.6% insitu rutile.
- Completion of 299 drill holes for 1,281 meters.
- In-country laboratory commissioned in Yaoundé.
- Net cash outflow from operating activities of $1.489 million.
- Financing activities contributed positively to cash flow.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
Call 1300 880 160
Start a chat
Schedule a call
